Article 1: Research on quaternary ammonium compounds (QACs) and their efficacy against MRSA infections found that these compounds can effectively combat the bacteria by disrupting its cell membrane. The study utilized a combination of in vitro experiments and animal models to demonstrate the potential of QACs as a treatment for MRSA. The findings suggest that QACs could be a promising alternative to traditional antibiotics in the fight against antibiotic-resistant bacteria like MRSA, offering a new avenue for treatment and prevention strategies.